UnitedHealth Group Inc (NYSE:UNH) had its price target hoisted by Bank of America Corporation from $210.00 to $214.00 in a research note released on Friday. The firm currently has a buy rating on the healthcare conglomerate’s stock.
A number of other equities analysts have also weighed in on UNH. UBS AG reissued a buy rating and set a $194.00 price objective (up previously from $193.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Deutsche Bank AG boosted their price objective on UnitedHealth Group from $187.00 to $197.00 and gave the stock a buy rating in a research note on Thursday. Sanford C. Bernstein reissued an outperform rating and set a $190.00 price objective on shares of UnitedHealth Group in a research note on Monday, July 10th. BidaskClub raised UnitedHealth Group from a buy rating to a strong-buy rating in a research note on Saturday, July 8th. Finally, Credit Suisse Group reissued an outperform rating and set a $200.00 price objective (up previously from $195.00) on shares of UnitedHealth Group in a research note on Thursday. One analyst has rated the stock with a hold rating, twenty-five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. UnitedHealth Group presently has an average rating of Buy and an average target price of $188.10.
UnitedHealth Group (NYSE:UNH) traded down 0.29% during mid-day trading on Friday, reaching $186.35. The company had a trading volume of 2,444,621 shares. The stock has a market capitalization of $179.58 billion, a price-to-earnings ratio of 23.85 and a beta of 0.63. The stock has a 50 day moving average of $178.98 and a 200 day moving average of $168.66. UnitedHealth Group has a 52 week low of $132.39 and a 52 week high of $188.66.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.17 by $0.20. The firm had revenue of $48.72 billion for the quarter, compared to analyst estimates of $48.21 billion. UnitedHealth Group had a return on equity of 21.73% and a net margin of 4.50%. The business’s revenue was up 9.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.81 earnings per share. Analysts anticipate that UnitedHealth Group will post $9.80 earnings per share for the current year.
WARNING: “UnitedHealth Group Inc (NYSE:UNH) Given New $214.00 Price Target at Bank of America Corporation” was originally reported by Ticker Report and is owned by of Ticker Report. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.tickerreport.com/banking-finance/2724198/unitedhealth-group-inc-nyseunh-given-new-214-00-price-target-at-bank-of-america-corporation.html.
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th were issued a dividend of $0.75 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $0.63. The ex-dividend date was Thursday, June 15th. This represents a $3.00 annualized dividend and a yield of 1.61%. UnitedHealth Group’s dividend payout ratio is 37.36%.
In other news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the transaction, the director now owns 75,735 shares in the company, valued at approximately $13,832,240.40. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP D Ellen Wilson sold 14,000 shares of the stock in a transaction dated Wednesday, April 19th. The shares were sold at an average price of $170.54, for a total value of $2,387,560.00. Following the completion of the transaction, the executive vice president now owns 31,993 shares in the company, valued at approximately $5,456,086.22. The disclosure for this sale can be found here. In the last quarter, insiders sold 30,378 shares of company stock worth $5,285,052. Company insiders own 0.89% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Hudson Valley Investment Advisors Inc. ADV increased its position in UnitedHealth Group by 3.5% in the second quarter. Hudson Valley Investment Advisors Inc. ADV now owns 20,242 shares of the healthcare conglomerate’s stock worth $3,753,000 after buying an additional 685 shares during the last quarter. TNB Financial increased its position in UnitedHealth Group by 25.0% in the second quarter. TNB Financial now owns 1,902 shares of the healthcare conglomerate’s stock worth $352,000 after buying an additional 380 shares during the last quarter. Advisors Capital Management LLC acquired a new position in UnitedHealth Group during the second quarter worth approximately $211,000. V Wealth Management LLC increased its position in UnitedHealth Group by 12.0% in the second quarter. V Wealth Management LLC now owns 2,442 shares of the healthcare conglomerate’s stock worth $452,000 after buying an additional 261 shares during the last quarter. Finally, BerganKDV Wealth Management LLC increased its position in UnitedHealth Group by 11.8% in the second quarter. BerganKDV Wealth Management LLC now owns 6,364 shares of the healthcare conglomerate’s stock worth $1,180,000 after buying an additional 673 shares during the last quarter. Institutional investors and hedge funds own 86.21% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.